AXQ Capital LP Invests $2.53 Million in The Sherwin-Williams Company $SHW

Key Points

• AXQ Capital initiated a $2.53 million position in Sherwin-Williams during the second quarter by purchasing 7,354 shares. Institutional investors and hedge funds collectively own 77.67% of the company.
• Sherwin-Williams exceeded quarterly expectations, reporting $3.70 in EPS and $6.79 billion in revenue, with sales rising 7.5% year over year. The company reaffirmed fiscal 2026 EPS guidance of $11.80–$12.20.
• The company declared a quarterly dividend of $0.80 per share, equal to a $3.20 annualized payout and a 1.0% yield. Analysts maintain a consensus “Moderate Buy” rating with an average price target of $386.29, although two insiders recently sold shares.

AXQ Capital LP bought a new position in shares of The Sherwin-Williams Company (NYSE:SHW - Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 7,354 shares of the specialty chemicals company's stock, valued at approximately $2,532,000.

Other large investors have also recently bought and sold shares of the company. Sapient Capital LLC increased its position in shares of Sherwin-Williams by 0.3% during the fourth quarter. Sapient Capital LLC now owns 9,176 shares of the specialty chemicals company's stock valued at $2,993,000 after purchasing an additional 30 shares during the period. Eastern Bank grew its position in Sherwin-Williams by 50.8% in the second quarter. Eastern Bank now owns 89 shares of the specialty chemicals company's stock valued at $31,000 after acquiring an additional 30 shares during the period. Deseret Mutual Benefit Administrators grew its position in Sherwin-Williams by 6.2% in the fourth quarter. Deseret Mutual Benefit Administrators now owns 527 shares of the specialty chemicals company's stock valued at $171,000 after acquiring an additional 31 shares during the period. Heartland Bank & Trust Co raised its stake in Sherwin-Williams by 2.8% during the first quarter. Heartland Bank & Trust Co now owns 1,174 shares of the specialty chemicals company's stock worth $376,000 after acquiring an additional 32 shares in the last quarter. Finally, Physician Wealth Advisors Inc. grew its stake in Sherwin-Williams by 8.5% during the first quarter. Physician Wealth Advisors Inc. now owns 432 shares of the specialty chemicals company's stock worth $138,000 after buying an additional 34 shares during the last quarter. 77.67% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Sherwin-Williams news, insider Justin Binns sold 13,500 shares of the business's stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $352.70, for a total value of $4,761,450.00. Following the sale, the insider owned 21,937 shares in the company, valued at approximately $7,737,179.90. The trade was a 38.10% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Karl J. Jorgenrud sold 7,886 shares of Sherwin-Williams stock in a transaction on Friday, August 7th. The shares were sold at an average price of $368.30, for a total transaction of $2,904,413.80. Following the completion of the sale, the insider owned 11,944 shares in the company, valued at $4,398,975.20. The trade was a 39.77% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 0.23% of the stock is currently owned by corporate insiders.

Sherwin-Williams Trading Up 0.3%

SHW opened at $332.35 on Friday. The firm's fifty day moving average is $343.29 and its two-hundred day moving average is $331.12. The firm has a market cap of $80.68 billion, a PE ratio of 30.63, a price-to-earnings-growth ratio of 2.47 and a beta of 1.09. The Sherwin-Williams Company has a twelve month low of $289.86 and a twelve month high of $377.77. The company has a debt-to-equity ratio of 2.16, a quick ratio of 0.46 and a current ratio of 0.73.

Sherwin-Williams (NYSE:SHW - Get Free Report) last announced its quarterly earnings results on Tuesday, July 28th. The specialty chemicals company reported $3.70 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.52 by $0.18. The company had revenue of $6.79 billion during the quarter, compared to analyst estimates of $6.60 billion. Sherwin-Williams had a net margin of 11.01% and a return on equity of 67.97%. The firm's revenue was up 7.5% on a year-over-year basis. During the same quarter in the previous year, the business earned $3.38 EPS. Sherwin-Williams has set its FY 2026 guidance at 11.800-12.200 EPS. Equities research analysts anticipate that The Sherwin-Williams Company will post 12.08 EPS for the current year.

Sherwin-Williams Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, September 11th. Shareholders of record on Friday, August 21st will be paid a $0.80 dividend. The ex-dividend date of this dividend is Friday, August 21st. This represents a $3.20 dividend on an annualized basis and a yield of 1.0%. Sherwin-Williams's payout ratio is presently 29.49%.

Wall Street Analysts Forecast Growth

SHW has been the subject of a number of recent analyst reports. Royal Bank Of Canada reaffirmed an "outperform" rating and set a $405.00 price target (up from $391.00) on shares of Sherwin-Williams in a report on Wednesday, July 8th. Berenberg Bank set a $380.00 target price on Sherwin-Williams in a report on Monday, June 8th. BMO Capital Markets restated an "outperform" rating and issued a $405.00 target price (up from $400.00) on shares of Sherwin-Williams in a research note on Wednesday, July 29th. Wells Fargo & Company set a $360.00 price objective on Sherwin-Williams and gave the stock an "equal weight" rating in a report on Wednesday, July 29th. Finally, Morgan Stanley reiterated an "overweight" rating and issued a $395.00 price target (up from $385.00) on shares of Sherwin-Williams in a report on Wednesday, July 29th. One analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $386.29.

Sherwin-Williams Company Profile

Sherwin-Williams NYSE: SHW is a global manufacturer and distributor of paints, coatings and related products. Founded in 1866 and headquartered in Cleveland, Ohio, the company supplies a broad range of coatings for residential, commercial and industrial applications. Its product offering includes architectural paints and stains, industrial and protective coatings, automotive finishes, and a variety of sundry products such as primers, sealants and specialty treatments used by professionals and consumers.

The company sells through multiple channels, including a large network of company-operated retail paint stores that serve professional contractors and do-it-yourself consumers, as well as through distributors and mass retailers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.